Pharmacist Medication Insights: Darzalex Faspro for Multiple Myeloma
August 16th 2021Daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen) was approved in July in combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma following their first or subsequent relapse.
Read More
Pharmacist Medication Insights: Phesgo for HER2-Positive Breast Cancer
July 26th 2021The combination of pertuzumab, trastuzumab and hyaluronidase–zzxf is indicated for adult patients with HER2-positive breast cancer that has spread to other parts of the body and for adult patients with early HER2-positive breast cancer.
Read More